{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:01:47Z","timestamp":1778637707498,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier","isbn-type":[{"value":"9780128177822","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.vh.2018.10.006","type":"book-chapter","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T21:02:52Z","timestamp":1545598972000},"page":"285-302","source":"Crossref","is-referenced-by-count":16,"title":["Primary Aldosteronism: Present and Future"],"prefix":"10.1016","author":[{"given":"John W.","family":"Funder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.vh.2018.10.006_bb0010","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: A preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.006_bb0015","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.006_bb0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.006_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pcad.2006.02.002","article-title":"Use of aldosterone antagonists in resistant hypertension","volume":"48","author":"Calhoun","year":"2006","journal-title":"Progress in Cardiovascular Diseases"},{"key":"10.1016\/bs.vh.2018.10.006_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1524-6175.2007.06334.x","article-title":"Low dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension","volume":"9","author":"Calhoun","year":"2007","journal-title":"Journal of Clinical Hypertension (Greenwich, Conn.)"},{"key":"10.1016\/bs.vh.2018.10.006_bb0035","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/bs.vh.2018.10.006_bb0040","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/bs.vh.2018.10.006_bb0045","first-page":"257","article-title":"The evolution of primary aldosteronism: 1954\u20131967","volume":"62","author":"Conn","year":"1966","journal-title":"Harvey Lectures"},{"key":"10.1016\/bs.vh.2018.10.006_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","article-title":"Normokalemic primary aldosteronism. A detectable cause of curable \u201cessential\u201d hypertension","volume":"193","author":"Conn","year":"1965","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/bs.vh.2018.10.006_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","article-title":"A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.vh.2018.10.006_bb0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1055\/s-0043-119802","article-title":"Primary aldosteronism: The next five years","volume":"49","author":"Funder","year":"2017","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/bs.vh.2018.10.006_bb0065","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.006_bb0070","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection diagnosis and treatment: An Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.006_bb0075","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2362.2011.02531.x","article-title":"High prevalence of autonomous aldosterone secretion among patients with essential hypertension","volume":"41","author":"Gouli","year":"2011","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2018.10.006_bb0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01476798","article-title":"Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading","volume":"58","author":"Helber","year":"1980","journal-title":"Klinische Wochenschrift"},{"key":"10.1016\/bs.vh.2018.10.006_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: A retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"The Lancet Diabetes and Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.006_bb0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5551\/jat.24455","article-title":"Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone producing adenomas","volume":"22","author":"Kitamoto","year":"2015","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"10.1016\/bs.vh.2018.10.006_bb0095","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2003-032149","article-title":"Distinguishing the antihypertensive and electrolyte effects of eplerenone","volume":"89","author":"Levy","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.006_bb0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimeric 11-beta-hydroxylase aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.1016\/bs.vh.2018.10.006_bb0105","first-page":"204","article-title":"Nadcisnienie tetnicze wywolane guzami korowo-nad-nerczowymi","volume":"8","author":"Lityniski","year":"1953","journal-title":"Polski Tygodnik Lekarski"},{"key":"10.1016\/bs.vh.2018.10.006_bb9000","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension","volume":"100","author":"Markou","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.006_bb0110","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: Uptake by primary care physicians in Europe","volume":"34","author":"Mulatero","year":"2016","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.vh.2018.10.006_bb0115","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.006_bb0120","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/js.2017-00134","article-title":"Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals","volume":"1","author":"Omata","year":"2017","journal-title":"Journal of the Endocrine Society"},{"key":"10.1016\/bs.vh.2018.10.006_bb9005","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.006_bb0125","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/ndt\/gfs587","article-title":"Regression of left ventricular hypertrophy in patients with primary aldosteronism\/low-renin hypertension on low-dose spironolactone","volume":"28","author":"Ori","year":"2013","journal-title":"Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"key":"10.1016\/bs.vh.2018.10.006_bb0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.vh.2018.10.006_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02155834","article-title":"Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism","volume":"9","author":"Simpson","year":"1953","journal-title":"Experientia"},{"key":"10.1016\/bs.vh.2018.10.006_bb0145","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.006_bb0150","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/bs.vh.2018.10.006_bb0155","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.006_bb0160","first-page":"3214","article-title":"Familial hyperaldosteronism type II: Description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene","volume":"83","author":"Torpy","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.006_bb0165","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/er.2017-00189","article-title":"Genetic causes of functional adrenocortical adenomas","volume":"38","author":"Zennaro","year":"2017","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.vh.2018.10.006_bb0170","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"}],"container-title":["Vitamins and Hormones","Aldosterone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672918300785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672918300785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:46:03Z","timestamp":1548121563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672918300785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128177822"],"references-count":34,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2018.10.006","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}